On Wednesday, Vivani Medical, Inc. (NASDAQ:VANI) said it intends to spin off Cortigent, Inc., a division that develops brain implant devices to help people recover critical body functions, as an ...

Mobia Medical has set the terms for its initial public offering, positioning the neurostimulation device company to raise ...

HOUSTON, TX, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, ...

Mobia Medical is pursuing an IPO to fund commercialization of its FDA-approved Vivistim neurostimulation device for stroke recovery. Read full analysis here.

Please provide your email address to receive an email when new articles are posted on . Focal cortex stimulation with an implantable device reduced seizure activity in more than 50% of participants at ...

HOUSTON, TEXAS, March 14, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that it has commenced sales of its second generation ...

CE Mark approval expands treatment options for patients suffering from the pain and disability associated with intractable chronic migraine ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc.

Medtronic alerted healthcare professionals in Europe to the risk of cardioversion-related damage to the Vanta implantable neurostimulator (INS), model 977006, During cardioversion, healthcare workers ...

Abbott Laboratories (NYSE:ABT) has recalled several models of its Proclaim and Infinity implantable neurostimulation devices over concerns that an external controller device may not be able to switch ...

Please provide your email address to receive an email when new articles are posted on . Olympic Ophthalmics announced that the FDA granted the 510(K) request for its second-generation iTEAR100 device, ...